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Burden of infectious diseases in South Asia
Anita K M Zaidi, Shally Awasthi, H Janaka deSilva
Infectious diseases are a major cause of death in South Asia, with children incurring a
disproportionate share of the burden. This review discusses the underlying causes of some of the
more common diseases and strategies to improve their detection and control
Preventable infections are a major cause of deaths and
disabilities in South Asia. Over two thirds of the
estimated 3.7 million deaths in children in South Asia
in the year 2000 were attributable to infections such as
pneumonia, diarrhoea, and measles.1 2 India now has
the second largest population with AIDS and HIV
infection in the world, and tuberculosis and chronic
hepatitis continue to threaten the lives of millions. Of
the overall burden of deaths related to infectious
disease in the region, around 63% are in children aged
under 5 years.3 Serious effort should be devoted to the
control of infectious disease if South Asian countries
are to meet their millennium development goal of two
thirds reduction in child mortality by 2015.
Sri Lanka alone among South Asian countries has
made remarkable progress in reducing the burden of
infectious disease, despite civil war and meagre
resources.
This review describes the burden of infectious
diseases of public health importance in South Asia, the
underlying risk factors, and strategies to improve
detection and control.
Sources and selection criteria
We searched PubMed and the databases of the World
Health Organization and Unicef for information on
infectious diseases of public health importance in
South Asia. We also reviewed the bibliographies of key
references and reviews for relevant information.
Risk factors for disease and death
People in South Asia are at a higher risk of developing
infectious diseases and dying from their illness than
people in industrialised countries.3 The root causes are
poverty and its associated problems of unhygienic
living conditions, malnutrition, illiteracy, and poor
access to clean water, toilet facilities, and quality health
care.
In South Asian children, poor nutrition and
deficiencies in micronutrients (vitamin A and zinc) are
important underlying risk factors for death due to
infectious diseases.4–6 Around half of the children in
South Asia are underweight or stunted, and malnutri-
tion contributes to an estimated 55% of deaths in
children.2–4
Estimating the burden of disease
Evidence based decision making in health requires the
availability of sound data, but good quality information
on the occurrence of infectious diseases is unavailable
from most of South Asia, especially on premature
mortality and loss of healthy life years in adult popula-
tions. Thus calculations of disease burden using
techniques such as disability adjusted life years
(DALYs) are fraught with difficulty; deaths and
disability caused by infections such as meningitis,
encephalitis, chronic hepatitis, leishmaniasis, congeni-
tal infections, rabies, and post-streptococcal rheumatic
heart disease in South Asian populations remain
hidden and unmeasured.
Major child killers
Acute respiratory infections and diarrhoea
Interventions targeted at diarrhoea and acute respira-
tory infections have resulted in substantial declines in
deaths in South Asian children, although these
diseases still account for almost half of the deaths (fig-
ure).7 2 Many children do not receive timely and
appropriate care (table 1). WHO and Unicef ’s strategy
for reducing deaths due to these conditions is centred
on the integrated management of childhood illness
(IMCI) initiative—a holistic approach encompassing
prevention, early detection, and treatment of common
childhood infections in countries with limited
resources.8 Although South Asian countries have
adopted the IMCI strategy in principle, implementa-
tion remains weak because of poorly functioning
health systems and fragmented referral pathways. Use
of vaccines against common pathogens of diarrhoea
and pneumonia—rotavirus, pneumococcus, and
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Haemophilus influenzae type b—has the potential to sig-
nificantly reduce morbidity and mortality due to diar-
rhoea and acute respiratory infections.
Neonatal infections
Neonatal infections are also a common cause of death
in South Asia and are under-recognised as a public
health problem. Regional neonatal mortality (deaths
in the first 28 days of life) is 46.3 per 1000 live births,
and an estimated 30-40% of these deaths are from
infections9 10; 300 000 to 400 000 deaths in India alone
each year can be attributed to neonatal infections
(table 1). Determinants include lack of antenatal care
and tetanus immunisation, unskilled birth attendants,
unclean delivery practices and poor infection control,
low birthweight babies, lack of exclusive breast
feeding, and low levels of carer seeking for sick
neonates.10–12
Integrated perinatal approaches based on solid
evidence, similar to the IMCI initiative, are urgently
needed to improve the survival of newborn babies in
South Asia. Community based approaches to prevent
and treat neonatal infections are especially important
and are being tested in the field in several South Asian
countries.12
The challenge of HIV and AIDS and the
control of tuberculosis
India is in the midst of an HIV and AIDS crisis, with over
4.58 million infected people, the highest burden in the
world after South Africa.13 Half a million people are pro-
jected to die from AIDS in India next year, and 600 000
are in urgent need of antiretroviral therapy.14 Prevalence
rates are lower in other South Asian countries but rising
slowly, especially in Nepal and Pakistan (table 2).13 14
The prevalence of HIV in India is heterogeneous,
the epidemic being concentrated in some (mainly)
southern states while most of India has low rates of
infection.14 In the states with the highest prevalence
(more than 1% of women presenting for antenatal check
ups test positive for HIV antibodies)—Maharashtra,
Tamil Nadu, Karnataka, Andhara Pradesh, Manipur,
and Nagaland—public health systems are over-
whelmed.14 The pattern of spread is also diverse, with
heterosexual transmission predominating in some
areas and intravenous drug use in others. As a result,
planning and implementing effective HIV prevention
programmes pose a major challenge for Indian health
officials. Locally relevant intervention programmes are
urgently needed rather than a one size fits all
approach. As a first step, behavioural surveillance pro-
grammes have been initiated in some areas in the
Indian AIDS II project to improve understanding of
transmission patterns.14
The presence of large numbers of people with AIDS
in a region where tuberculosis is highly endemic creates
a volatile situation for further spread of tuberculosis.
South Asian countries are struggling to control tubercu-
losis through the implementation of WHO’s directly
observed therapy short course (DOTS) strategy.
Although some progress has been made in expanding
coverage, tuberculosis remains highly prevalent in most
of South Asia, with Afghanistan having the highest rates
(see table 2).15 Pakistan has been particularly unsuccess-
ful in its efforts at tuberculosis control, with only 24% of
the population covered under the WHO’s strategy, and
low case notification rates.15 Major constraints to
tuberculosis control include weak public health infra-
structure, staff shortages, inadequate funding, lack of
awareness about the strategy among private practition-
ers, and multidrug resistant tuberculosis.15
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Table 1 Selected indicators of infectious disease in South Asian children
Infectious disease Afghanistan Bangladesh Bhutan India Maldives Nepal Pakistan Sri Lanka
Acute respiratory infections:
No of annual deaths* 60 240 82 320 — 576 480 — 18 240 135 600 <1000
% of children <5 years affected in previous two weeks† — 18 — 19 70 34 24 —
% taken to health provider — 27 — 64 40 18 53 —
Diarrhoea:
No of annual deaths* 60 240 82 320 — 576 480 — 18 240 135 600 <1000
% of children <5 years affected in previous two weeks† 20 6 — 19 8 27 26 5
% receiving increased fluids plus continued feeding 33‡ 61‡ — 27‡ — 11 19 34‡
Neonatal infections:
Mortality per 1000 live births§ — 47 — 48 — 47 42 10
No of annual deaths¶ 32 630 53 207 — 388 473 — 11 928 73 410 1133
Data sources: Unicef (www.childinfo.org) and Hyder et al.11
*Extrapolated from Black et al.2
†Before survey.
‡Data for oral rehydration therapy use only.
§Estimated for 1995.9
¶One third estimated to be due to neonatal infections. Data for Afghanistan are extrapolated.2
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The unmeasured burden of malaria,
typhoid, and dengue
Malaria and typhoid are among the common causes of
febrile illness in children in South Asia. Outbreaks of
mosquito borne dengue fever and dengue haemor-
rhagic disease are also increasingly reported.16 Malaria
is responsible for less than 5% of deaths in children in
South Asia but is a serious contributor to morbidity
and chronic anaemia.2 Millions of South Asians have
debilitating typhoid and dengue infections every year,
but reliable data on the annual number of cases are
hard to come by because these diseases require labora-
tory confirmation, which is not routinely attempted.
Rates of typhoid fever as high as 980 per 100 000
population have been reported from urban slums in
Delhi, and Salmonella is the commonest bacterial
pathogen identified from bloodstream infections in
South Asia.17–19 Infection rates in children under 5 years
of age are much higher than previously thought.17 19
Public health approaches to infection control are
needed, especially as drug resistant malaria and
typhoid become increasingly common. An effective
vaccine against Salmonella typhi is available but not
included in routine childhood immunisations.
The hepatitis B and C epidemics
High rates of hepatitis B infection in many South Asian
countries are attributed to unsafe blood supply, reuse of
contaminated syringes, lack of maternal screening to
prevent perinatal transmission, and delay in the
introduction of hepatitis B vaccine. India, Pakistan, and
Bangladesh have the highest rates of infection, with
prevalence ranging from 2% to 8% in different popula-
tion groups.20 Prevalence rates in Sri Lanka are under
1%.21 Hepatitis C infections in South Asia are also
rising, and chronic liver diseases increasingly burden
the region’s health systems.21 22 Prevalence rates were
estimated to be 1-2.4% in 1999.22 Infections seem to be
acquired at an early age, and reuse of contaminated
syringes is strongly implicated in transmission of
hepatitis B and hepatitis C infection.23 24
Antimicrobial drug resistance and
untreatable infections
Widespread resistance to commonly used, affordable
antimicrobial agents in South Asia has made the treat-
ment of infections such as pneumonia, dysentery,
typhoid, malaria, neonatal sepsis, urinary tract infec-
tions, and tuberculosis challenging in resource limited
environments.25 26 For example, most pneumococci
and H influenzae in South Asia are now resistant to
cotrimoxazole, and fluoroquinolone resistance in
Salmonella is rapidly increasing.25 27 Many factors
underlie increased antibiotic use and misuse in
developing countries.26 28 Infectious diseases are much
more common, and appropriate microbiological facili-
ties are rarely available or affordable, leading to
empirical use of antibiotics for a wide range of illnesses.
Antibiotics are freely available over the counter in
South Asia, and self medication is common. Antibiotic
misuse by unskilled practitioners is also rampant. Poor
drug quality owing to use beyond expiry date,
improper manufacture, or storage conditions may also
contribute to resistance as subinhibitory levels of anti-
biotics can favour selection of resistant microbes.28
The optimum solution to the problem of antibiotic
resistance remains investment in the infrastructure
required to reduce the burden of infectious diseases. In
the short term the best approaches rely on increasing
awareness about antibiotic misuse, developing guide-
lines for practitioners in different settings, restricting the
choice of antibiotics, and providing feedback to
practitioners on local patterns of resistance.28 WHO has
developed guidelines for rational antibiotic use in devel-
oping countries, which can be adapted for local use.29
The glaring immunisation gap
Only Sri Lanka has been able to sustain high levels of
immunisation coverage among its children (table 3).
The regional average for children receiving three doses
of diphtheria, pertussis, and tetanus vaccine in South
Asia is only 58%.7 Only half of South Asian children
receive a single dose of measles vaccine, and measles
Table 2 Burden of HIV, AIDS, and tuberculosis in South Asian countries
Infectious disease Afghanistan Bangladesh Bhutan India Maldives Nepal Pakistan Sri Lanka
HIV and AIDS
No affected — 13 000 <100 4 580 000 <100 60 000 73 000* 4800
HIV prevalence in adults 15-49 years (%) — 0.02 <0.01 0.8 <0.01 0.5 0.10 <0.10
Deaths from AIDS:
Estimated in 2000 — 11 000 <100 350 000 <100 3,000 3500 500
Projected for 2005 — 17 000 <100 500 000 <100 6,000 11 000 1000
Antiretroviral therapy:
No of people needing therapy in 2003 — 1800 14 600 000 14 8000 — 680
No of people receiving therapy in 2003 — 5 5 13 000 0 250 — 25
Tuberculosis
Estimated incidence:
No of cases† 314 233 — 178 — 201 171 58
No of new smear positive cases† 141 105 — 79 — 90 77 26
Notification rate† 21 29 — 38 — 58 7.5 23
Estimated % of new cases with multidrug
resistance
7.3 1.4 — 3.4 — — 9.6 —
Population coverage (%)‡ 20 95 — 45 — 84 24 64
Data sources: WHO,13 15 UNAIDS/WHO Global Report, 2000.15
*Data available for 1999.14
†Per 100 000 population.
‡By WHO’s directly observed therapy short course strategy.
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eradication has not received priority attention.7 Poor
routine immunisation coverage is responsible for the
delay in polio eradication—India, Pakistan, and
Afghanistan are now among only a few countries in the
world with wild-type polio (see table 3).30 Good news is
the recent introduction of hepatitis B vaccine in immu-
nisation programmes through the support of the Glo-
bal Alliance for Vaccines and Immunization. Future
funding of hepatitis B vaccination, however, remains
uncertain.
As South Asian countries struggle to immunise
their children with these basic vaccines, children in
industrialised countries are being protected against an
increasing array of infectious agents through use of
new vaccines against H influenzae type b, pneumococci,
meningococci, hepatitis A, and varicella and other vac-
cines, such as against rotavirus, are soon to be licensed.
Poor routine immunisation coverage and lack of access
to newer vaccines have created a huge gap in immuni-
sation between children living in industrialised
countries and those living in developing countries.
Reducing the burden of infectious
diseases
In the short term a few simple and proved
interventions may reduce the number of deaths and
disabilities caused by many infectious diseases. These
include promotion of exclusive breast feeding, hand
washing, clean water, use of oral rehydration therapy
for diarrhoea, improving nutritional status among
mothers and young children, better immunisation cov-
erage including addition of effective new vaccines, pro-
vision of good antenatal care and clean delivery, and
improving care seeking behaviour for serious
illness.31–33 Tuberculosis, HIV, and hepatitis prevention
activities (for example, increasing awareness, behaviour
modification, use of autodestruct syringes) should be
integrated within an essential health package delivered
through a strengthened public health system in the
region. In this, Sri Lanka and Kerala (India) have
shown the way.
Surveillance systems
Policy planners need to make evidence based decisions
for improving population health. The ability to
measure disease burden, the global effort for
eradication of polio, the recent outbreaks of severe
acute respiratory syndrome and avian influenza in
many Asian countries, and the plague scare in India
show the importance of establishing sustainable and
robust detection and early warning systems for
infectious diseases. Eradication or control requires the
ability to detect these diseases and use the information
for preventing further spread. Surveillance systems for
infectious diseases are, however, lacking in most of
South Asia. Requirements of notification for commu-
nicable diseases are rarely enforced, and most
healthcare activity takes place in the private sector—
information not usually captured by the rudimentary
government information systems for health manage-
ment. Epidemiologists and microbiologists are not
involved in disease control activities, and vital
registration systems for births and deaths are absent or
inadequate. Additionally, many disease outbreaks with
major consequences for public health and trade, such
as haemorrhagic fevers, influenza, and severe acute
respiratory syndrome, require sophisticated facilities
and expertise of the type available only in a well
equipped national reference laboratory. As the recent
outbreak of avian influenza in Pakistan’s poultry popu-
lation illustrates, absence of such facilities and dissemi-
nation of reliable information in a timely manner can
have devastating consequences for both public health
and industry.
A noteworthy success story is the recent establish-
ment of surveillance for acute flaccid paralysis as a
proxy measure for detecting poliomyelitis in develop-
ing countries. Surveillance systems do not have to be
expensive. John and coworkers developed a surveil-
lance system at district level serving over 5 million
people in Tamil Nadu (India), with a per capita cost of
less than one US cent per year.34 The system monitors
occurrence of vaccine preventable infections, meningi-
tis, encephalitis, rabies, hepatitis, malaria, typhoid, chol-
era, HIV infection, and antimicrobial resistant patho-
gens. Major contributors towards the programme’s
success were involvement of staff in the government
and private sector, sentinel laboratory surveillance,
simple reporting procedures, and regular feedback to
data providers. This concept was later extended to all
districts of Kerala. Such a model of public-private sec-
tor partnership may be replicable in sentinel districts
of all South Asian countries, enhancing our ability to
detect and monitor the occurrence of infectious
diseases important to public health, as well as to meas-
ure the effectiveness of targeted interventions.
Conclusions
Most of South Asia is in the early phase of an
epidemiological transition where disease patterns
Table 3 Comparison of selected indicators for immunisation in children in South Asia
Characteristic Afghanistan Bangladesh Bhutan India Maldives Nepal Pakistan Sri Lanka
% receiving three doses of diphtheria, pertussis, and tetanus 44 69 88 64 92 72 56 99
% receiving measles vaccination 46 65 — 56 — 71 54 99
No of cases of polio in 2003 8 0 0 224 0 0 99 0
Data sources: Unicef (www.unicef.org/infobycountry/southasia.html),7 and WHO Global polio eradication initiative (www.who.int).
Additional educational resources
Unicef (www.childinfo.org)
Information on child health and survival
World Health Report 2003—Shaping the Future. Geneva:
WHO. (http://www.who.int/whr/en/)
Information on burden of diseases
Bellagio Child Survival Study Group, Lancet 2003
Series of articles on child survival
Information for patients
Children’s Vaccine Program
(www.childrensvaccine.com/html/parents_teens.htm)
Information on vaccines for parents
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change from infectious to more chronic degenerative
ones. Infections remain among the commonest causes
of premature mortality in South Asia, and the impact
of HIV and AIDS may delay the epidemiological
transition. Sound governmental policies, especially
adequate investments in female education and public
health systems, can bring about a rapid decrease in the
burden of infectious diseases in the rest of South Asia,
as shown by Sri Lanka.
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A memorable patient
Spiritual relief
As healthcare professionals, we regularly encounter
complex decision making with regard to patient
consent. While working as a volunteer doctor in a
Tibetan hospital in northern India, I came across an
unusual example of difficulty gaining consent.
An elderly monk presented with a sharp thoracic
back pain of sudden onset and shortness of breath. A
chest radiograph revealed a large pneumothorax. This
was aspirated successfully, but recurred the following
day. We discussed the need for a chest drain, but the
monk withheld consent, as he felt he was close to death
and did not want any invasive procedures performed.
After further discussion, he conceded that he would
only consent to such treatment if he could obtain a
“divination” from His Holiness the Dalai Lama; it is
local practice for Tibetans occasionally to seek advice
and guidance from their spiritual leader. Consequently,
although he remained in respiratory distress, a postal
request was made for a divination. Ten hours later, the
divination was obtained, and a chest drain was inserted
without complication.
This was a particularly unusual example of consent by
proxy and emphasises the need to consider patients’
cultural and spiritual beliefs when obtaining consent.
Sarah Hull general practitioner, London
Many thanks to the Tibetan Delek Hospital, Dharamsala,
northern India.
We welcome articles up to 600 words on topics such as
A memorable patient, A paper that changed my practice,My most
unfortunate mistake,or any other piece conveying
instruction, pathos, or humour. Please submit the article
on http://submit.bmj.com Permission is needed from the
patient or a relative if an identifiable patient is referred to.
We also welcome contributions for “Endpieces,” consisting
of quotations of up to 80 words (but most are considerably
shorter) from any source, ancient or modern, which have
appealed to the reader.
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